Oh Yaz, There May be a Problem

LawyersandSettlements.com

August 5, 2009. By Brenda Craig

Carlsbad, CA: Large storm clouds are gathering over Bayer HealthCare as more and more women are reporting serious physical and emotional problems connected to the Yasmin birth control pill . “I have a 30-year-old client who had a severe stroke after three weeks of taking Yaz,” says attorney Ron Laba. “She is partially paralyzed and debilitated to the point where she cannot work, cannot drive a car and cannot do most activities of daily living without assistance.”

Laba is just one of the attorneys preparing to file product liability (failure to warn) cases against Bayer on behalf of clients who have come forward with serious injuries they believe are related to the use of the Yasmin and Yaz birth control pills. “We are now trying to determine how many cases there are out there now,” says Laba. “These are women who have either suffered a heart attack or deep vein thrombosis or a pulmonary embolism or sometimes kidney or renal problems. They are typically young women between the ages of 17 and 35 or 40.”

Yasmin is the now top selling birth control pill in the US with an estimated 20 percent share of the market. Laba believes that there is significant amount of information available to show that Bayer did not provide sufficient warnings to consumers about possible complications. “We believe that the warnings are not sufficient,” he says. “This product has been marketed as safer and more effective than traditional second or third generation birth control pills, but we believe that from information we have, that is not the case.”

MORE…

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.